Antialergicos

Chlorpheniramine Maleate
• not recommended in children less than 6 yrs of age

Loratadine
• >2 yr

Desloratadine
• safety and efficacy of syrup and oral tablets have not been established in children less than 6 months of age
• Idiopathic urticaria, chronic: (12 mo to 5 y old) 2.5 mL (1.25 mg) of syrup ORALLY once daily
• Idiopathic urticaria, chronic: (6 to 11 mo old)2 mL (1 mg) of syrup ORALLY once daily
• Perennial allergic rhinitis: (12 mo to 5 y old) 2.5 mL (1.25 mg) of syrup ORALLY once daily
• Perennial allergic rhinitis: (6 to 11 mo old) 2 mL (1 mg) of syrup ORALLY once daily

Cetirizine Hydrochloride
• Perennial allergic rhinitis: (6-23 months) 2.5 mg (0.5 tsp (5 mg/5 mL solution)) ORALLY once daily; the dose in children 12 to 23months of age can be increased to a maximum dose of 5 mg per day given as 2.5 mg every 12 hours
• Urticaria, chronic: (6-23 months) 2.5 mg (0.5 tsp (5 mg/5 mL solution)) ORALLY once daily; the dose in children 12 to 23 months of age can be increased to a maximum dose of 5 mg per day given as 2.5 mg every 12 hours

Levocetirizine Dihydrochloride
• Idiopathic urticaria, chronic,uncomplicated skin manifestations: 6 months to 5 yr old, 1.25 mg ORALLY once daily in the evening; do not exceed recommended dose
• Perennial allergic rhinitis: 6 months to 5 yr old, 1.25 mg ORALLY once daily in the evening; do not exceed recommended dose

Hydroxyzine Hydrochloride
• >6 yr

Fexofenadine Hydrochloride
• safety and efficacy not established in children less than 6 months ofage
• Idiopathic urticaria, chronic: 6 months to 2 years, 15 mg ORALLY twice daily

Ketotifen Fumarate
• Safety and effectiveness in children below 3 yr of age not established

Dexchlorpheniramine Maleate
• > 2 yr

Oxymetazoline Hydrochloride
• safety and efficacy not established in children under 6 years

Fluticasone Furoate
• > 2 yr

Fluticasone Propionate
•(cream) safety and efficacy not established in those younger than 3 months of age
• (lotion) safety and efficacy not established in those younger than 1 year of age
• (ointment) safety and efficacy not established in pediatric patients
• Atopic dermatitis: (3 months and older) cream, apply TOPICALLY to affected area once or twice daily; rub in gently
• Atopic dermatitis: (1year and older) lotion, apply TOPICALLY to affected area once daily; rub in gently
• Disorder of skin, Corticosteroid-responsive dermatoses: (3 months and older) cream, apply thin film TOPICALLY to affected areas twice daily; rub in gently

Budesonide
• Asthma: JET NEBULIZER RESPULE, age 1 to 8 yr, (previous therapy bronchodilators alone) initial, 0.5 mg once daily or divided twicedaily, MAX 0.5 mg/day; (previous therapy inhaled corticosteroids) initial, 0.5 mg once daily or divided twice daily, MAX 1 mg/day; (previous oral corticosteroids therapy) initial, 0.5 mg twice daily or 1 mg once daily, MAX 1 mg/day

Prednisone
• Pediatric Dosing
• Adrenal insufficiency: 5 to 60 mg/day ORALLY initially, vary dose depending on patient response
• Allergic disorder(Severe), Intractable to adequate trials of conventional treatment: 5 to 60 mg/day ORALLY initially, vary dose depending on patient response
• Asthma: (moderate and severe exacerbation, 12 yr and younger; NHLBI asthma guidelines) 1 to 2 mg/kg/day ORALLY in 2 divided doses (maximum 60 mg/day) until PEF reaches 70% of predicted or personal best; outpatient burst, 1 to 2 mg/kg/day ORALLY in 2 divideddoses (maximum 60 mg/day) for a total of 3-10 days
• Asthma: (long-term therapy, 11 yr and younger; NHLBI asthma guidelines) 0.25 to 2 mg/kg ORALLY daily in the morning or every other day as needed for control of asthma
• Asthma: (moderate and severe exacerbation, greater than 12 yr ; NHLBI asthma guidelines) 40 to 80 mg/day ORALLY in 1 or 2 divided doses until PEF reaches 70% of...